Reportlinker Adds Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising healthcare costs coupled with the economic downturn continue to shape the healthcare landscape

Friday, May 27, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 26, 2011 announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising healthcare costs coupled with the economic downturn continue to shape the healthcare landscape


Aging populations, the growing prevalence of chronic disease, greater use of expensive treatments, and expanding public healthcare coverage in markets such as the US are stretching existing healthcare resources. Healthcare payers are also feeling the impact of the global economic downturn through reduced funding via taxation as a result of rising unemployment.

Features and benefits

* An overview of demographic trends in developed and emerging markets

* Analysis of disease burden in developed and emerging markets

* Insight into the economic trends in developed and developing markets

* Summary of measures taken by governments to reduce healthcare costs


The increasingly aging global population, changing dietary habits toward a Western-style diet are key risk factors driving up the prevalence of chronic diseases Nevertheless, earlier intervention, as well as improvements in diagnosis and treatments, is helping to reduce mortality rates in a number of these diseases In the developed markets.

Aging populations and declining numbers of people of working age are stretching public healthcare budgets, an issue that is exacerbated as a result of the global economic downturn. Consequently, a number of countries have or plan to introduce a number of strategies to offset this.

Government cost containment measures such as reducing healthcare budgets (at least in real terms) and implementing pricing and reimbursement cuts, as well as bolstering generic uptake, together with the increasingly tough regulatory environment are already having a negative impact on the pharmaceutical industry

Your Key questions answered

* Evaluate key socio-demographic factors driving healthcare expenditure in both developed and emerging markets

* Gain insight into how the economic downturn has impacted the healthcare landscape

* Review the cost-containment measures implemented by governments in developed markets and how these impact the pharma industry

Executive Summary

Strategic scoping and focus

Key findings

Key growth drivers and resistors facing healthcare payers and pharma

Disease Burden

Socioeconomic trends


Demographic trends in the major developed and emerging markets

Population growth rates in the 12 major markets are slowing

Aging populations are a major strain on healthcare provisions in developed markets

Governments in emerging markets have implemented healthcare reforms to expand healthcare coverage

The key aims of healthcare reforms in developing emerging markets include the following:

Birth rates will continue to fall across most markets


Disease burden

Ischemic heart disease and cerebrovascular disease

Trachea, bronchus and lung cancers

Chronic obstructive pulmonary disease

Lower respiratory tract infections

Colon and rectum cancers

Alzheimer's disease

Diabetes mellitus type 1 and 2

Stomach cancer

Breast cancer

Diseases associated with poverty are still rife in emerging markets


Impact of the economic downturn on both developed and emerging markets

A background to the economic crisis

Debt trap analysis

Government strategies to cut the budget deficit

EU economies have looked to make public spending cuts in order to reduce budget deficits

Unpaid liabilities and bond yields are both assisting and threatening US economic recovery

Japan's budget deficit is projected to reach almost 10% of GDP in 2010

Australia has been less affected by the downturn than other OECD countries

Developing markets with weaker ties to the West were less affected by the global economic crisis

The impact of the economic downturn on the pharmaceutical industry

Countries are containing healthcare costs in order to help reduce their budget deficits

Pharmaceuticals are a key target for government healthcare spending cuts

Government strategies to contain healthcare and pharmaceutical costs

Healthcare spending has slowed in several markets as governments bring in austerity measures

Pricing and reimbursement cuts were key elements included in austerity measures in many developed markets

Driving generic uptake will create further savingsIn addition to pricing and reimbursement cuts, many governments have recently introduced or modified existing measures in order to enhance generic uptake. These include:


Publications and online articles

Datamonitor reports and products


Exchange rates used in this report

To order this report:

Pathology Industry: Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising healthcare costs coupled with the economic downturn continue to shape the healthcare landscape

Pathology Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

CONTACTNicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store